TL;DR
This study identifies Bifidobacterium pseudocatenulatum NCU-08, isolated from centenarian feces, as a potent probiotic that delays aging in mice. It achieves this by increasing L-tryptophan (L-Trp) levels, which are then converted to NAD+ in the brain, activating the Sirt1/P53/P21/Rb pathway to combat aging.
What Problem Does This Paper Address?
The global population is aging rapidly, leading to increased healthcare burdens and a need for effective strategies to promote healthy aging. While gut microbiota is recognized as a key player in aging, research into novel probiotics with anti-aging properties is lagging, hindering clinical applications. This paper addresses this gap by identifying and characterizing a specific probiotic strain, B. pseudocatenulatum NCU-08, and elucidating its anti-aging mechanisms.
Methods
The researchers employed a multi-pronged approach:
- Metagenomics and Culturomics: To identify potential probiotic strains from the fecal samples of centenarians.
- In Vitro Screening: To assess the probiotic properties (growth performance, acid resistance, bile salt resistance) of isolated strains.
- Animal Models: Using senescence-accelerated mouse tendency-8 (SAMP8) mice to evaluate the anti-aging effects of the selected probiotic and L-tryptophan.
- Behavioral Assessments: Pole tests, hanging wire tests, and open field tests to measure motor function, balance, and exploratory behavior.
- Histopathology (H&E staining): To assess neuronal damage in the hippocampus.
- Western Blotting: To quantify the levels of age-related proteins like β-galactosidase (β-gal).
- Targeted Metabolomics: To identify key metabolites involved in the anti-aging process, specifically focusing on tryptophan metabolism.
- Gut Microbiota Analysis: High-throughput sequencing (16S rRNA) to analyze changes in microbial composition.
- Cellular Models (HT22 cells): Using D-galactose-induced senescence to investigate the molecular mechanisms in vitro.
- RT-qPCR: To measure the expression of aging-related genes.
- Inhibitor Studies: Using EX-527, a Sirt1 inhibitor, to confirm the role of the Sirt1/P53/P21/Rb pathway.
Datasets
The study utilized fecal samples from seven centenarians in Jiangxi Province, China, as the primary source for microbial isolation. For animal studies, SAMP8 mice (a model of accelerated aging) and SAMR1 mice (a normal aging control) were used. HT22 mouse hippocampal neuronal cells were used for in vitro experiments.
Key Insights and Ideas
- Centenarian Microbiota as a Source: The study highlights the value of studying the gut microbiota of exceptionally long-lived individuals to discover novel anti-aging interventions.
- L-Tryptophan as a Key Mediator: The research strongly implicates L-tryptophan (L-Trp) as the crucial molecule produced by B. pseudocatenulatum NCU-08 that mediates its anti-aging effects.
- Gut-Brain Axis Connection: The findings demonstrate that gut-derived L-Trp can reach the brain and influence neuronal function, underscoring the importance of the gut-brain axis in aging.
- Sirt1 Pathway as a Target: The study provides compelling evidence that the Sirt1/P53/P21/Rb signaling pathway is a critical downstream target for L-Trp's anti-aging actions.
- Probiotic Potential of B. pseudocatenulatum: This work establishes B. pseudocatenulatum NCU-08 as a promising candidate for developing next-generation probiotics for anti-aging applications.
Key Results
- B. pseudocatenulatum NCU-08 was isolated from centenarian feces and demonstrated superior probiotic properties.
- In SAMP8 mice, NCU-08 treatment significantly improved motor function, reduced hippocampal neuronal damage, and decreased β-galactosidase (β-gal) levels (0.81 vs. 1.13, p<0.05).
- Targeted metabolomics revealed a significant increase in L-tryptophan (L-Trp) in mice treated with NCU-08 (14878.6 ng/mL vs. 5464.99 ng/mL, p<0.01).
- L-Trp administration alone replicated many of NCU-08's anti-aging effects, including improved motor function and reduced β-gal.
- In HT22 cells, L-Trp treatment increased cell viability and reduced β-gal, while upregulating Sirt1 and downregulating P53, P21, and Rb.
- Inhibition of Sirt1 with EX-527 reversed the anti-aging effects of both NCU-08 and L-Trp in both cellular and animal models.
Limitations and Future Work
The authors acknowledge several limitations:
- Small Centenarian Sample Size: The study used a limited number of centenarians, suggesting the need for larger cohorts in future research to confirm findings and assess age-group differences in microbiota.
- Limited Organ Scope: The study focused primarily on the brain and gut, with less comprehensive analysis of NCU-08's effects on other organs. Future work could explore multi-organ anti-aging potential.
- Quantification of Colonization: The colonization of B. pseudocatenulatum in mice was not precisely quantified. Digital PCR or metagenomics approaches are suggested for more accurate measurement.
- Germ-Free Animal Studies: To definitively isolate the effects of NCU-08 and rule out confounding factors from endogenous tryptophan metabolism, studies using germ-free animals are recommended.
- Mechanism of L-Trp Production: Further investigation is needed to elucidate whether NCU-08 produces L-Trp directly or via substrate utilization, potentially through genomic analysis.
- Gene Knockout for Sirt1 Validation: While EX-527 is a potent inhibitor, gene knockout techniques could provide more definitive validation of Sirt1's role.
Future work could focus on discovering additional anti-aging strains from centenarian feces and exploring genetic modification of B. pseudocatenulatum using synthetic biology for enhanced anti-aging capabilities.
Summary updated